Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

This study has been completed.

Study NCT00309556 Information provided by Austrian Breast & Colorectal Cancer Study Group

First Received: March 31, 2006 Last Updated: December 29, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2011
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)